Showing 1 - 20 of 27 results
ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.
Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.
Using PET and simulations to verify the accuracy of dose and range in advanced therapy with heavy ions
An ANSTO radiochemist has been awarded a scholarship to carry out research at the world-renowned Sloan Kettering Cancer Center in New York.
The Accelerator Science group purse a broad research program with the aims of improving the performance and reliability of our accelerators, increasing their research capabilities and developing the next generation of accelerator technology.
A world-class national research facility that uses accelerator technology to produce a powerful source of light-X rays and infrared radiation a million times brighter than the sun.
Neutron Capture Enhanced Particle Therapy developed at ANSTO.
The project aims to engage the wider cultural heritage community in addition to our internal research.
Role at ANSTO
Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia
Evidence for existence of a highly exotic and elusive state of matter, known as a magnetic ‘spin nematic’ phase in a natural mineral called linarite.
The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.
Highlights of the Energy Materials Project.